Diamyd Medical

Request correction

Corporate brand

Unclaimed

Diamyd Medical is a Swedish clinical-stage diabetes company active in pharmaceutical development.

Last updated September 15, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development, dedicated to finding a cure for autoimmune diabetes. Its share is listed on Nasdaq Stockholm First North (ticker: DMYD B). The company also provides Diamyd® autoantigens, including full-length recombinant human GAD65, for scientific preclinical research use only.

History

Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development, dedicated to finding a cure for autoimmune diabetes. Its share is listed on Nasdaq Stockholm First North (ticker: DMYD B). The company provides Diamyd® autoantigens, including full-length recombinant human GAD65 in two forms, for scientific preclinical research use only.

Products and positioning

Clinical-stage diabetes company dedicated to finding a cure for autoimmune diabetes.

Diamyd® autoantigens
Provided for research purposes; full-length recombinant human GAD65 is supplied in 2 forms for scientific preclinical research use only.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/diamyd-medical · Editorial policy · How profiles are compiled